Shuttle Pharmaceuticals Holdings Inc share price logo

Shuttle Pharmaceuticals Holdings Inc Share Price

NASDAQ: SHPH

Small Cap

$1.71

-0.13

(-7.07%)

Live

as on

Shuttle Pharmaceuticals Holdings Inc Stock Performance

as on February 4, 2026 at 8:38 pm IST

  • Day's Low

    Day's High

    $1.72
    $1.79
    downward going graph

    -0.58%

    Downside

    4.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.26
    $19.75
    downward going graph

    26.32%

    Downside

    1054.97%

    Upside

    downward going graph

Shuttle Pharmaceuticals Holdings Inc share price movements today

Previous Close
$1.84
Open
$1.78
Volume
35.3K
Day's Low - High
$1.72 - $1.79
52 Week Low - High
$1.26 - $19.75

Shuttle Pharmaceuticals Holdings Inc Historical Returns

1 Month Return
+ 1.66 %
3 Month Return
-36.33 %
1 Year Return
-89.63 %
3 Year Return
-99.55 %
5 Year Return
0 %

Shuttle Pharmaceuticals Holdings Inc Stock Fundamentals & Key Indicators

Check Shuttle Pharmaceuticals Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-27176.18%

Shuttle Pharmaceuticals Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shuttle Pharmaceuticals Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Shuttle Pharmaceuticals Holdings Inc image
Shuttle Pharmaceuticals Holdings Inc
NA$4.3MNANA0.00%
Regencell Bioscience Holdings Ltd image
Regencell Bioscience Holdings Ltd
NA$14.4BNANA0.00%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$21.6BNA18.0840.65%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$46.2BNA22.5413.81%
Viatris Inc. image
Viatris Inc.
HOLD$15.2B-24%-21.95-26.13%
See all

Stock Returns calculator for Shuttle Pharmaceuticals Holdings Inc Stock including INR - Dollar returns

The Shuttle Pharmaceuticals Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Shuttle Pharmaceuticals Holdings Inc investment value today

Current value as on today

₹13,507

Returns

₹86,493

(-86.49%)

Returns from Shuttle Pharmaceuticals Holdings Inc Stock

₹90,366 (-90.37%)

Dollar Returns*

₹3,873 (+3.87%)

Shuttle Pharmaceuticals Holdings Inc Stock’s Investor Sentiment and Interest

Investment in Shuttle Pharmaceuticals Holdings Inc Shares on INDmoney has grown by 5700.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:5700.00% versus previous 30 day period

Search interest for Shuttle Pharmaceuticals Holdings Inc Stock has increased by 900% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:900% versus previous 30 day period

Shuttle Pharmaceuticals Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
0
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-1
-1
-1
-1
-1
-3
-1
-2
-3
-2
EBITDA
-1
-1
-1
-1
-1
-3
-1
-3
-3
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
-1
-1
-2
-3
-1
-3
-3
-2
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-2
-1
-1
-1
-2
-3
-1
-3
-3
-2
Net Profit Margin
0.00%
0.00%
-16989.44%
0.00%
-21035.78%
0.00%
-27809.13%
0.00%
0.00%
0.00%

Shuttle Pharmaceuticals Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
0
-1
-2
-5
-7
EBITDA
0
-1
-4
-3
-7
Interest Expense
0
0
0
2
1
Depreciation
0
0
0
0
0
Income Before Tax
0
-1
-4
-6
-9
Income Tax Expense
0
0
0
0
-
Net Income
0
-1
-4
-6
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Shuttle Pharmaceuticals Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-1
-1
-1
-2
-3
-1
-3
-3
-2
Operating Cash Flow
-1
-1
-1
-1
-1
-2
-2
-3
-2
Investing Cash Flow
0
0
0
1
1
2,912
-
-
-
Financing Cash Flow
-
0
0
0
0
4
5
3
0
Change in Cash
-1
-1
-1
0
0
1
2
0
-2

Shuttle Pharmaceuticals Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
0
0
0
0
-1
-3
-6
-9
Operating Cash Flow
0
0
0
0
0
-2
-5
-7
Investing Cash Flow
0
-
0
0
-
-
-2
2
Financing Cash Flow
0
0
0
0
0
10
2
3
Change in Cash
0
0
0
0
0
7
-5
0

Global Institutional Holdings in Shuttle Pharmaceuticals Holdings Inc

Funds
Holdings
UBS Group AG
0.31%
Bank of America Corp
0%
TWO SIGMA SECURITIES, LLC
0%
Citadel Advisors Llc
0%
Tower Research Capital LLC
0.01%
See all

Insights on Shuttle Pharmaceuticals Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Regencell Bioscience Holdings Ltd has given 3552.6% return, outperforming this stock by 3652.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regencell Bioscience Holdings Ltd has given 26995.2% return, outperforming this stock by 27084.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SHPH stock has moved down by -15.6%

About Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). Its product candidates include Ropidoxuridine, a Phase II, clinical-stage radiation sensitizer, a platform of HDAC inhibitors (SP-1-161, SP-2-225 and SP-1-303), and two preclinical, prostate cancer-oriented diagnostics assets: PC-RAD Test, a blood test to predict clinical response to radiation therapy and PSMA-B ligand for potential use as a theranostic agent. Ropidoxuridine (IPdR) is for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. SP-1-161 is a candidate lead of compounds demonstrating activation of the ATM gene product (mutated in Ataxia-Telangiectasia). SP-2-225 is a candidate lead of compounds demonstrating Class II (HDAC6) selective inhibition. SP-1-303 is a candidate Class I HDAC inhibitor with preferential efficacy against ER positive cancers.
OrganisationShuttle Pharmaceuticals Holdings Inc
Headquarters401 Professional Drive, Gaithersburg, MD, United States, 20879
CEOMr. Christopher Robert Cooper BBA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Shuttle Pharmaceuticals Holdings Inc

Name

Title

Dr. Milton Brown CSC, M.D., Ph.D.

Co-Founder

Ms. Yuying Liang B.A., CPA

Chief Financial Officer

Dr. Mira Jung Ph.D.

Co-Founder & Chief Scientific Officer for Biology

Dr. Tyvin A. Rich M.D.

Chief Clinical Officer & Chief Medical Officer

Mr. Timothy J. Lorber CPA

Consultant

Mr. Michael P. Vander Hoek

Vice President for Operations and Regulatory

Mr. Christopher Robert Cooper BBA, M.B.A.

Interim Chief Executive Officer

FAQs

What is Shuttle Pharmaceuticals Holdings Inc share price today?

Shuttle Pharmaceuticals Holdings Inc share price today is $1.71 as on . Shuttle Pharmaceuticals Holdings Inc share today touched a day high of $1.79 and a low of $1.72.

What is the 52 week high and 52 week low for Shuttle Pharmaceuticals Holdings Inc share?

Shuttle Pharmaceuticals Holdings Inc share touched a 52 week high of $19.75 on and a 52 week low of $1.26 on . Shuttle Pharmaceuticals Holdings Inc stock price today i.e. is trending at $1.71,which is 91.34% down from its 52 week high and 35.71% up from its 52 week low.

What is Shuttle Pharmaceuticals Holdings Inc's market capitalisation today?

Shuttle Pharmaceuticals Holdings Inc market capitalisation is $0.00T as on .

How to invest in Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Shuttle Pharmaceuticals Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Shuttle Pharmaceuticals Holdings Inc Shares that will get you 0.8772 shares as per Shuttle Pharmaceuticals Holdings Inc share price of $1.71 per share as on February 4, 2026 at 8:38 pm IST.

What is the minimum amount required to buy Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) from India?

Indian investors can start investing in Shuttle Pharmaceuticals Holdings Inc (SHPH) shares with as little as ₹90.453 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Shuttle Pharmaceuticals Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Shuttle Pharmaceuticals Holdings Inc share’s latest price of $1.71 as on February 4, 2026 at 8:38 pm IST, you will get 5.8480 shares of Shuttle Pharmaceuticals Holdings Inc. Learn more about fractional shares .